Ikaria Bioscience Pty Ltd
Clinical trials sponsored by Ikaria Bioscience Pty Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cholesterol drug RN5681 enters first human tests Results expected Feb 2027 (estimated)
- New Weight-Loss drug combo tested in early trial Results expected Feb 2027 (estimated)